Metformin Dosing and Administration Guidelines

Standard Adult Dosing

The American Diabetes Association recommends starting metformin at 500 mg orally twice daily or 850 mg once daily, taken with meals, to minimize gastrointestinal side effects 1
The lower starting dose minimizes gastrointestinal side effects, which are typically transient, as reported by the American Academy of Pediatrics 2
Increase metformin dose by 500 mg weekly or 850 mg every 2 weeks based on glycemic control and tolerability, as suggested by the American Diabetes Association 1

For patients with estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73m², standard dosing without adjustment is recommended, according to Praxis Medical Insights 3
For patients with eGFR 45-59 mL/min/1.73m², continue standard dosing but consider dose reduction in patients with advanced age or concomitant liver disease, as advised by Praxis Medical Insights 3, 4
For patients with eGFR 30-44 mL/min/1.73m², reduce metformin dose to half the maximum recommended dose, as recommended by Praxis Medical Insights 3
Metformin is contraindicated in patients with eGFR <30 mL/min/1.73m², according to Praxis Medical Insights 3

Monitor renal function at least every 3-6 months in patients with eGFR <60 mL/min/1.73m², as recommended by Praxis Medical Insights 3, 4
Check vitamin B12 levels in patients on metformin for >4 years, as advised by Praxis Medical Insights 3, 4

Do not advance metformin doses too quickly if gastrointestinal side effects occur; decrease to previous dose and retry advancement later, as suggested by the American Diabetes Association 1
Implement "sick day rules" to temporarily stop metformin during acute illness that could cause acute kidney injury, as recommended by Praxis Medical Insights 3
Generic immediate-release metformin is the most cost-effective first choice, according to the American Diabetes Association 1

The American Diabetes Association recommends dividing the immediate-release dose into twice-daily administration with meals to minimize gastrointestinal side effects 5

If gastrointestinal symptoms develop after the switch, temporarily reduce to the previous lower dose and attempt dose advancement later, as suggested by the American Diabetes Association 5

The National Kidney Foundation recommends monitoring renal function at baseline and periodically, especially if eGFR <60 mL/min/1.73m² where monitoring should occur every 3-6 months 6
For patients on metformin >4 years, the National Kidney Foundation suggests monitoring vitamin B12 levels 6

Generic immediate-release metformin is more cost-effective than extended-release formulations, which may be the primary reason for switching, according to the American Diabetes Association 5